NextRNA Therapeutics
Edit info- Founded: 2020
- Location: Boston, MA
- Employee range: 11 - 50
- Funding: $46.8M A Mar 2022; $9.3M seed
nextrnatx.com linkedin.com job board
Business:
Treatments Targeting Non-Coding RNA
About:
NextRNA Therapeutics is developing small molecule therapeutics that work by targeting long non-coding RNAs. The majority of RNAs found in cells do not make proteins, instead they are non-coding and play various regulatory roles within cells. Long non-coding RNAs (lncRNAs) can function by interacting with various proteins, RNA and DNA, with their dysregulation observed in various diseases. NextRNA is using their drug discovery engine to identify, validate and selectively disrupt disease-relevant lncRNAs with small molecules.
Jobs:
News:
Women in Biotech: NextRNA CEO Dominique Verhelle - GBH News
googlenews
Dec 4, 2024
New hires
external-link
Bayer partners with NextRNA to develop lncRNA-targeting cancer therapies - Pharmaceutical Business Review
googlenews
Aug 29, 2024
Science/business updates
external-link
Bayer teams up with lncRNA-focused NextRNA in $547m deal - Pharmaceutical Technology
googlenews
Aug 28, 2024
Funding-related
external-link
Long non-coding RNAs: what’s behind the growing “dark genome” buzz? - Labiotech.eu
googlenews
Sep 10, 2024
Science/business updates
external-link
September 26 2024
NextRNA Therapeutics Expands Executive Team with Appointment of Jesse Smith, PhD as Chief Scientific Officer
More
web
Dec 23, 2024
New hires
external-link
Our CEO Dominique Verhelle participated in a panel discussion yesterday focused on non-coding RNA (ncRNA) and epigenetics at the #DarkGenomeSymposium in NYC. Dominique shared NextRNA's therapeutic app
linkedin
Nov 23, 2024
Science/business updates
external-link
Our Co-Founder & CEO, Dominique Verhelle, will give a corporate presentation on Monday, Sep. 30th at 1:30 pm ET at Chardan’s 8th Annual Genetic Medicines Conference in NYC.
There is increasing evide
linkedin
Oct 23, 2024
Science/business updates
external-link
Bayer and NextRNA Therapeutics enter oncology partnership worth $547m - PMLiVE
googlenews
Aug 29, 2024
Funding-related
external-link
NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD - Business Wire
googlenews
Sep 26, 2023
New hires
external-link
August 28 2024
Bayer partners with RNA drugmaker to develop new cancer therapies
BioPharma Dive
web
Dec 23, 2024
Science/business updates
external-link
Our team recently set sail for an unforgettable team-building adventure in Newport, RI, where we raced 12-meter America's Cup sailboats! It was not only an amazing experience navigating the open water
linkedin
Nov 23, 2024
New hires
external-link
March 01 2022
NextRNA Launches with $56 Million in Funding to Bring Transformative Non-coding RNA-directed Medicines to Patients
More
web
Dec 23, 2024
Funding-related
external-link
Bayer, NextRNA to Develop Therapeutics Targeting Oncology - Yahoo Finance
googlenews
Aug 29, 2024
Science/business updates
external-link
August 28 2024
Boston biotech signs deal with Bayer worth up to $547 million
Boston Business Journal
web
Dec 23, 2024
Science/business updates
external-link
NextRNA Therapeutics Appoints Charles Kunsch, Ph.D. to Board of Directors
crunchbase
Dec 12, 2024
New hires
external-link
NextRNA Launches with $56 Million in Funding to Bring Transformative Non-Coding RNA-Directed Medicines to Patients - Business Wire
googlenews
Mar 1, 2022
Funding-related
external-link
Bayer pens $547M biobucks pact with biotech pushing the boundaries of noncoding RNA - Fierce Biotech
googlenews
Aug 28, 2024
Funding-related
external-link
NextRNA Therapeutics Appoints Seasoned Industry Leader Charles Kunsch, Ph.D. to Board of Directors - Business Wire
googlenews
Dec 12, 2024
New hires
external-link
Bayer inks deal with NextRNA on IncRNA-driven diseases - The Pharma Letter
googlenews
Aug 28, 2024
Science/business updates
external-link
A new biotech out of Dana-Farber wants to join the long non-coding RNA party, with help from Bob Langer - Endpoints News
googlenews
Mar 1, 2022
Science/business updates
external-link
I look forward to participating in this partnership-focused panel at the Longwood Healthcare Leaders Boston CEO forum next week to discuss how NextRNA and Bayer's collaboration is reflective of each o
linkedin
Dec 23, 2024
Science/business updates
external-link
Fenwick Represents NextRNA Therapeutics in Strategic Collaboration with Bayer - Fenwick & West LLP
googlenews
Aug 28, 2024
Science/business updates
external-link
September 22 2022
NextRNA Therapeutics to Participate in Upcoming BioPharm America and Chardan’s 6th Annual Genetic Medicines Conference
M
web
Dec 23, 2024
Science/business updates
external-link
At NextRNA, we believe in the power of community and the importance of supporting and empowering women. Recently, a group of our amazing employees had the honor of volunteering at Rosie's Place, a san
linkedin
Sep 23, 2024
Science/business updates
external-link
August 28 2024
Bayer pens $547M biobucks pact with biotech pushing the boundaries of noncoding RNA FierceBiotech
Fierc
web
Dec 23, 2024
Funding-related
external-link
September 04 2024
Bayer and NextRNA sign $500M+ lncRNA oncology deal
Inside Precision Medicine
web
Dec 23, 2024
Funding-related
external-link
Our Co-Founder and CEO, Dominique Verhelle, will participate in a panel on Oct. 28 at 4:10pm at the Longwood Healthcare Leaders Boston CEO forum, titled "Aligning Priorities for the Partnership." As p
linkedin
Oct 23, 2024
Science/business updates
external-link
The ‘Junk’ Genome May Actually Unlock The Next Cancer Treatment
linkedin
Oct 23, 2024
Science/business updates
external-link
Bayer and NextRNA: One partnership, two oncology programs - BioXconomy
googlenews
Sep 25, 2024
Science/business updates
external-link
Bayer and NextRNA Sign $500M+ IncRNA Oncology Deal - Inside Precision Medicine
googlenews
Sep 4, 2024
Funding-related
external-link
NextRNA Therapeutics on LinkedIn: #bio2024 #rna #ncrna #lncrna #bio24 #cancer #oncology…
crunchbase
May 30, 2024
Science/business updates
external-link
August 28 2024
Bayer and NextRNA Therapeutics enter strategic collaboration to develop small molecules targeting long non-coding RNAs (lncRNAs) in
web
Dec 23, 2024
Science/business updates
external-link
June 21 2023
The Long and Short of It: Exploring the Therapeutic Potential of lncRNAs
Q&A with Susan Carpenter, PhD
Associate Professor of M
web
Dec 23, 2024
Science/business updates
external-link
October 23 2024
The ‘Junk’ Genome May Actually Unlock The Next Cancer Treatment
Forbes
More
web
Dec 23, 2024
Science/business updates
external-link
NextRNA Therapeutics Names Dominique Verhelle as CEO and Expands Leadership Team
crunchbase
Aug 11, 2022
New hires
external-link
We’re excited to announce that Charles Kunsch has been appointed to our Board of Directors!
Read the press release: https://bit.ly/4fkC2Jj
Currently a Venture Partner at Dreavent Capital and previo
linkedin
Dec 16, 2024
New hires
external-link
September 10 2024
Long non-coding RNAs: what’s behind the growing “dark genome” buzz?
Labiotech.eu
web
Dec 23, 2024
Science/business updates
external-link
Boston biotech signs deal with Bayer worth up to $547M - The Business Journals
googlenews
Aug 28, 2024
Funding-related
external-link
We’re excited to announce the appointment of Jesse Smith as NextRNA’s Chief Scientific Officer! With his deep expertise in pioneering first-in-class targeted small molecule therapies, Dr. Smith is ide
linkedin
Oct 23, 2024
New hires
external-link
August 28 2024
Bayer signs $547 million pact with NextRNA in oncology push
Bloomberg
More
web
Dec 23, 2024
Funding-related
external-link
Bayer partners with RNA drugmaker to develop new cancer therapies - BioPharma Dive
googlenews
Aug 28, 2024
Science/business updates
external-link
December 08 2022
NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit
More
web
Dec 23, 2024
Science/business updates
external-link
Bayer partners with RNA startup launched out of Dana-Farber - Endpoints News
googlenews
Aug 28, 2024
Science/business updates
external-link
September 26 2023
NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD
More
web
Dec 23, 2024
New hires
external-link
June 06 2023
The Long and Short of It: Exploring the Therapeutic Potential of lncRNAs
Q&A with John Mattick, PhD
Professor of RNA Biology at
web
Dec 23, 2024
Science/business updates
external-link
Bayer signs $547 million pact with Boston-based NextRNA in oncology push - The Boston Globe
googlenews
Aug 28, 2024
Funding-related
external-link
Bayer Signs $547 Million Pact With NextRNA in Oncology Push - Bloomberg
googlenews
Aug 28, 2024
Funding-related
external-link
August 28 2024
Bayer partners with NextRNA on lncRNA-targeted small molecules for cancer
FirstWord Pharma
web
Dec 23, 2024
Science/business updates
external-link
NextRNA Therapeutics Raises $56M in Seed and Series A Funding
crunchbase
Mar 1, 2022
Funding-related
external-link
Lilly taps RNA biotech for $1 billion weight-loss collaboration - Chemical & Engineering News
googlenews
Sep 4, 2024
Funding-related
external-link
Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-Coding RNAs (lncRNAs) in Oncology - Business Wire
googlenews
Aug 28, 2024
Science/business updates
external-link
Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-Coding RNAs (lncRNAs) in Oncology
crunchbase
Aug 28, 2024
Science/business updates
external-link
July 10 2023
The Long and Short of It: Exploring the Therapeutic Potential of lncRNAs
Q&A with Rory Johnson, PhD
Associate Professor, Univer
web
Dec 23, 2024
Science/business updates
external-link
August 11 2022
NextRNA Therapeutics names Dominique Verhelle as CEO and expands leadership team
More
web
Dec 23, 2024
New hires
external-link
December 12 2024
NextRNA Therapeutics Appoints Seasoned Industry Leader Charles Kunsch, Ph.D. to Board of Directors
More
web
Dec 23, 2024
New hires
external-link
NextRNA Therapeutics Expands Executive Team with Appointment of Jesse Smith, PhD as Chief Scientific Officer
crunchbase
Sep 26, 2024
New hires
external-link
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com